Black Rock Inc. Autolus Therapeutics PLC Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Black Rock Inc. holds 4,436,102 shares of AUTL stock, worth $10.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,436,102

Previous 4,055,920 9.37%

Holding current value

$10.2 Million

Previous $25.9 Million 40.34%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$3.33 - $5.68 $1.27 Million - $2.16 Million	380,182 Added 9.37%	4,436,102 $15.4 Million
Q1 2024 May 10, 2024	BUY	$5.39 - $7.29 $14.6 Million - $19.7 Million	2,700,581 Added 199.26%	4,055,920 $25.9 Million
Q4 2023 Feb 13, 2024	BUY	$2.13 - $6.63 $1.25 Million - $3.9 Million	588,242 Added 76.68%	1,355,339 $8.73 Million
Q3 2023 Nov 13, 2023	SELL	$2.32 - $3.36 $241,041 - $349,093	-103,897 Reduced 11.93%	767,097 $1.79 Million
Q2 2023 Aug 11, 2023	SELL	$1.64 - $3.21 $23,784 - $46,554	-14,503 Reduced 1.64%	870,994 $2.07 Million
Q1 2023 May 12, 2023	BUY	$1.75 - $2.25 $828,182 - $1.06 Million	473,247 Added 114.8%	885,497 $1.63 Million
Q4 2022 Feb 13, 2023	SELL	$1.74 - $3.27 $60,212 - $113,158	-34,605 Reduced 7.74%	412,250 $783,000
Q3 2022 Nov 14, 2022	SELL	$2.04 - $3.76 $42,821 - $78,926	-20,991 Reduced 4.49%	446,855 $956,000
Q2 2022 Aug 12, 2022	BUY	$2.04 - $4.68 $165,509 - $379,697	81,132 Added 20.98%	467,846 $1.33 Million
Q1 2022 May 12, 2022	SELL	$3.52 - $5.46 $299,266 - $464,203	-85,019 Reduced 18.02%	386,714 $1.61 Million
Q4 2021 Feb 10, 2022	BUY	$5.1 - $7.0 $1.64 Million - $2.25 Million	321,761 Added 214.55%	471,733 $2.45 Million
Q3 2021 Nov 09, 2021	BUY	$5.32 - $7.37 $506,096 - $701,115	95,131 Added 173.47%	149,972 $983,000
Q2 2021 Aug 11, 2021	BUY	$4.78 - $7.96 $262,139 - $436,534	54,841 New	54,841 $364,000

Others Institutions Holding AUTL

# of Institutions

104

Shares Held

163M

Call Options Held

2.8K

Put Options Held

13.4K

View Full List

About Autolus Therapeutics plc

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $208M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

More about AUTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account